DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use.

Name: DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use.
Author: Klingler, Maximilian

DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use. — المؤلف: Klingler, Maximilian — Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20200330

المؤلف: Klingler, Maximilian
النشر: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20200330
الوصف: 1010-1016 p.
الموضوعات: Amino Acid Sequence؛ Animals؛ Cell Line؛ Female؛ Heterocyclic Compounds, 1-Ring؛ Mice؛ Molecular Imaging؛ Oligopeptides